Dr Hale is formally trained in small animal internal medicine with a comparative postdoctoral NIH fellowship in transfusion medicine. She has been an active translational scientist in the cellular therapy world for over 25 years with successful translation of lyophilized small molecules and cells for use in transfusion and regenerative medicine. Dr. Hale is a recognized speaker and author with recent publications in cellular therapy for use in control of shock, hemorrhage and endotheliopathy.
Her clinical practice limited to small animal Internal Medicine and Regenerative Medicine has been focused on immune mediated diseases as well as utilization of cellular therapies for immunomodulation, anti-inflammatory promotion and endotheliopathy. Dr. Hale has successfully completed comparative veterinary clinical trials developed to support the One Health Initiative as both Level 1 evidence-based medicine for common transfusion and cellular practice and preclinical support for human cellular therapies.
Active in organized veterinary medicine through the New Mexico Veterinary Medical Association as a recent president, she has been involved in the legislative clarification of transfusion and cellular therapy for animals. She is a member and past board member of the Association of Veterinary Hematology and Transfusion Medicine.